Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years

Urology

Volumn 77, Issue 4, 2011, Pages 787-791

  Haramis, Georgios ^a   Mues, Adam C ^a   Rosales, Juan Carlos ^a   Okhunov, Zhamshid ^a   Lanzac, Alberto Perez ^a   Badani, Ketan ^a   Gupta, Mantu ^a   Benson, Mitchell C ^a   McKiernan, James ^a   Landman, Jaime ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CRYOABLATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KIDNEY TUMOR; MALE; NEPHRECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR GROWTH; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CRYOSURGERY; FEMALE; HUMANS; KIDNEY CORTEX; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; WATCHFUL WAITING;

EID: 79953868335     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.09.031     Document Type: Article

References (27)

1. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol. 2001;166:1611-1623.
2. Chow WH, Devesa SS, Warren JL, et al. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628-1631. (Pubitemid 29211773)
3. Parsons JK, Schoenberg MS, Carter HB. Incidental renal tumors: casting doubt on the efficacy of early intervention. Urology. 2001;57:1013-1015. (Pubitemid 32455557)
4. Pahernik S, Ziegler S, Roos F, et al. Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol. 2007;178:414-417. (Pubitemid 47030507)
5. Remzi M, Ozsoy M, Klingler HC, et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol. 2006;176:896-899. (Pubitemid 44142601)
6. Kouba E, Smith A, McRackan D, et al. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol. 2007;177:466-470. (Pubitemid 46054008)
7. Kato M, Suzuki T, Suzuki Y, et al. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol. 2004;172:863-866. (Pubitemid 39096408)
8. Lamb GW, Bromwich EJ, Vasey P, et al. Management of renal masses inpatients medically unsuitable for nephrectomy - natural history, complications, and outcome. Urology. 2004;64:909-913. (Pubitemid 39469504)
9. Abou Youssif T, Kassouf W, Steinberg J, et al. Active surveillance for selected patients with renal masses: updated results with longterm follow-up. Cancer. 2007;110:1010-1014. (Pubitemid 47312866)
10. Crispen PL, Viterbo R, Fox EB, et al. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008;112:1051-1057. (Pubitemid 351304589)
11. Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma - a meta-analysis and review. J Urol. 2008;179:1227-1233.
12. Abouassaly R, Lane BR, Novick AC. Active surveillance of renal masses in elderly patients. J Urol. 2008;180:505-508.
13. Berger DA, Megwalu VA II, et al. Impact of comorbidity on overall survival in patients surgically treated for renal cell carcinoma. Urology. 2008;72:359-363.
14. Remzi M, Katzenbeisser D, Waldert M, et al. Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small. BJU Int. 2007;99:1002-1006. (Pubitemid 46587912)
15. Frank I, Blute ML, Cheville JC, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170(6 Pt. 1):2217-2220. (Pubitemid 37413960)
16. Gill IS, Matin SF, Desai MM. Comparative analysis of laparoscopic versus open partial nephrectomy. J Urol. 2003;170:64-68. (Pubitemid 36734412)
17. Chawla SN, Crispen PL, Hanlon AL, et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425.
18. Rosales JC, Haramis G, Moreno J, et al. Active surveillance of renal cortical neoplasms. J Urol. 2010;183:1698-1702.
19. Mues AC, Haramis G, Badani K, et al. Active surveillance for larger (cT1bN0M0 and cT2N0M0) renal cortical neoplasms. Urology. 2010;76:620-623.
20. Klaver S, Joniau S, Van Poppel H. Surveillance as an option for the treatment of small renal masses. Adv Urol. 2008:705958:1-6.
21. Kunkle DA, Crispen PL, Chen DY, et al. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177:849-853.
22. Neuzillet Y, Lechevallier E, Andre M, et al. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0cm) renal masses. J Urol. 2004;171:1802-1805. (Pubitemid 38501006)
23. Silverman SG, Gan YU, Mortele KJ. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology. 2006;240:6-22. (Pubitemid 43902590)
24. Schmidbauer J, Remzi M, Memarsadeghi M, et al. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol. 2008;53:1003-1011.
25. Crispen PL, Viterbo R, Boorjian SA, et al. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer. 2009;115:2844-2852.
26. Crispen PL, Viterbo R, Fox EB, et al. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008;112:1051-1057. (Pubitemid 351304589)
27. Volpe A, Panzarella T, Rendon RA, et al. The natural history of incidentally detected small renal masses. Cancer. 2004;100:738-745. (Pubitemid 38176851)